Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03321 | 34046015 | Front Endocrinol (Lausanne) | Epigenetics of Hepatic Insulin Resistance. | 2021 | Details |
| A03322 | 34046014 | Front Endocrinol (Lausanne) | Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice. | 2021 | Details |
| A03323 | 34044131 | Clin Gastroenterol Hepatol | Validation of the Dallas Steatosis Index to Predict Nonalcoholic Fatty Liver Disease in the UK Biobank Population. | 2021 | Details |
| A03324 | 34043974 | J Am Coll Radiol | Opportunistic Screening of Patients for Hepatic Steatosis: Clinical Follow-Up and Diagnostic Yield. | 2021 | Details |
| A03325 | 34043691 | PLoS One | Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study. | 2021 | Details |
| A03326 | 34043630 | PLoS One | Association between toothbrushing and non-alcoholic fatty liver disease. | 2021 | Details |
| A03327 | 34043417 | Circ Res | Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia. | 2021 | Details |
| A03328 | 34043368 | J Proteome Res | Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients. | 2021 | Details |
| A03329 | 34043121 | Dig Dis Sci | Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention. | 2021 | Details |
| A03330 | 34041467 | JHEP Rep | A nationwide population-based prospective study of cirrhosis in Iceland. | 2021 | Details |
| A03331 | 34041187 | J Family Med Prim Care | Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi. | 2021 | Details |
| A03332 | 34040583 | Front Endocrinol (Lausanne) | Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. | 2021 | Details |
| A03333 | 34040411 | J Inflamm Res | Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice. | 2021 | Details |
| A03334 | 34040322 | World J Gastroenterol | Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. | 2021 | Details |
| A03335 | 34039490 | J Hepatol | The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. | 2021 | Details |
| A03336 | 34037463 | Am J Physiol Gastrointest Liver Physiol | Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications. | 2021 | Details |
| A03337 | 34037296 | Liver Int | Impact of major depression and antidepressant use on alcoholic and non-alcoholic fatty liver disease: A population-based study. | 2021 | Details |
| A03338 | 34036256 | JHEP Rep | A human liver chimeric mouse model for non-alcoholic fatty liver disease. | 2021 | Details |
| A03339 | 34036255 | JHEP Rep | Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past. | 2021 | Details |
| A03340 | 34035098 | BMJ Open | PUTRA-Adol study: protocol for an observational follow-up study to assess the tracking of dietary patterns linked to cardiometabolic risk factors and its prospective relationship with non-alcoholic fatty liver disease, carotid intima-medial thickness and mental well-being during adolescence in Malaysia. | 2021 | Details |
| A03341 | 34034750 | Lipids Health Dis | Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis. | 2021 | Details |
| A03342 | 34034748 | Lipids Health Dis | A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test. | 2021 | Details |
| A03343 | 34034671 | BMC Gastroenterol | Waist-to-height ratio and non-alcoholic fatty liver disease in adults. | 2021 | Details |
| A03344 | 34033923 | Clin Gastroenterol Hepatol | Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD. | 2021 | Details |
| A03346 | 34033261 | Curr Protoc | Intravital Microscopy for the Study of Hepatic Glucose Uptake. | 2021 | Details |
| A03348 | 34032730 | Medicine (Baltimore) | Acupuncture for type 2 diabetes mellitus with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2021 | Details |
| A03349 | 34032283 | Eur J Clin Invest | Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver. | 2021 | Details |
| A03350 | 34032030 | J Korean Med Sci | Severe Phenotype of Non-alcoholic Fatty Liver Disease in Pediatric Patients with Subclinical Hypothyroidism: a Retrospective Multicenter Study from Korea. | 2021 | Details |
| A03351 | 34031913 | J Gastroenterol Hepatol | TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2021 | Details |
| A03352 | 34031802 | Dig Dis Sci | Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study). | 2021 | Details |
| A03353 | 34031390 | Nat Commun | PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling. | 2021 | Details |
| A03354 | 34031327 | Med J Malaysia | Liver fibrosis associated with adipose tissue and liver inflammation in an obesity model. | 2021 | Details |
| A03355 | 34031143 | Diabetes Care | The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes. | 2021 | Details |
| A03356 | 34030288 | Sci Total Environ | Serum lipids mediate the relationship of multiple polyaromatic hydrocarbons on non-alcoholic fatty liver disease: A population-based study. | 2021 | Details |
| A03357 | 34029949 | Biomed Pharmacother | The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine model. | 2021 | Details |
| A03358 | 34029162 | Am J Physiol Endocrinol Metab | β2-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states. | 2021 | Details |
| A03359 | 34028830 | Med J Aust | Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study. | 2021 | Details |
| A03360 | 34028753 | Methods Mol Biol | Mouse Models of Liver Fibrosis. | 2021 | Details |
| A03361 | 34027933 | Minerva Gastroenterol (Torino) | The role of elastography in non-alcoholic fatty liver disease. | 2021 | Details |
| A03362 | 34027591 | Dig Dis Sci | Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival. | 2021 | Details |
| A03363 | 34027561 | Arch Toxicol | Infections at the nexus of metabolic-associated fatty liver disease. | 2021 | Details |
| A03364 | 34027340 | JHEP Rep | Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets. | 2021 | Details |
| A03365 | 34027337 | JHEP Rep | Defatting strategies in the current era of liver steatosis. | 2021 | Details |
| A03366 | 34027276 | Hepatol Commun | The Patient's Perspective in Cirrhosis: Unmet Supportive Care Needs Differ by Disease Severity, Etiology, and Age. | 2021 | Details |
| A03367 | 34027269 | Hepatol Commun | Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial. | 2021 | Details |
| A03368 | 34027267 | Hepatol Commun | SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH. | 2021 | Details |
| A03369 | 34027266 | Hepatol Commun | The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017. | 2021 | Details |
| A03370 | 34027265 | Hepatol Commun | Impact of Sodium Glucose Cotransporter 2 Inhibitors on Nonalcoholic Fatty Liver Disease Complicated by Diabetes Mellitus. | 2021 | Details |
| A03371 | 34027116 | Clin Exp Hepatol | Comparative study of the effects of Abexol and atorvastatin in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A03372 | 34027109 | Clin Exp Hepatol | Non-alcoholic fatty liver disease and lipotoxicity. | 2021 | Details |
| A03373 | 34026558 | Toxicol Rep | Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview. | 2021 | Details |
| A03374 | 34026086 | Food Sci Nutr | Alpha-lipoic acid alleviates NAFLD and triglyceride accumulation in liver via modulating hepatic NLRP3 inflammasome activation pathway in type 2 diabetic rats. | 2021 | Details |
| A03375 | 34025683 | Front Immunol | Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD. | 2021 | Details |
| A03376 | 34025577 | Front Endocrinol (Lausanne) | Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII. | 2021 | Details |
| A03377 | 34025131 | J Ginseng Res | Effect of Korean Red Ginseng on metabolic syndrome. | 2020 | Details |
| A03378 | 34025071 | World J Gastroenterol | Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis. | 2021 | Details |
| A03379 | 34024536 | Clin Nutr ESPEN | Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: A randomized controlled trial. | 2021 | Details |
| A03381 | 34023517 | Spine J | Cardiovascular and metabolic morbidity following spinal cord injury. | 2021 | Details |
| A03383 | 34022879 | BMC Endocr Disord | The application value of serum 25(OH)D3, uric acid, triglyceride, and homeostasis model assessment of insulin resistance in male patients with hyperuricemia combined with hypogonadism. | 2021 | Details |
| A03384 | 34022528 | Bioorg Med Chem | Discovery of novel modulators for the PPARα (peroxisome proliferator activated receptor α): Potential therapies for nonalcoholic fatty liver disease. | 2021 | Details |
| A03385 | 34022222 | J Biol Chem | Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide. | 2021 | Details |
| A03386 | 34022107 | Liver Int | A Twitter discourse analysis of negative feelings and stigma related to NAFLD, NASH and obesity. | 2021 | Details |
| A03387 | 34020377 | Comput Methods Programs Biomed | Training of computational algorithms to predict NAFLD activity score and fibrosis stage from liver histopathology slides. | 2021 | Details |
| A03388 | 34019941 | J Hepatol | The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease. | 2021 | Details |
| A03390 | 34019560 | PLoS One | Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting. | 2021 | Details |
| A03391 | 34019353 | Vopr Pitan | [Specialized products for dietary correction of the diet of patients with non-alcoholic steatohepatitis]. | 2021 | Details |
| A03392 | 34019202 | Mol Cell Biochem | New insights into BMP9 signaling in liver diseases. | 2021 | Details |
| A03393 | 34017413 | Am J Transl Res | Correlation of CD3+/CD4+, and serum CK-18 fragment levels with glucose and lipid metabolism in elderly type 2 diabetes patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A03394 | 34017254 | Front Pharmacol | Geniposide and Chlorogenic Acid Combination Improves Non-Alcoholic Fatty Liver Disease Involving the Potent Suppression of Elevated Hepatic SCD-1. | 2021 | Details |
| A03395 | 34017133 | Nat Med | XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. | 2021 | Details |
| A03396 | 34017059 | Exp Mol Med | The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease. | 2021 | Details |
| A03397 | 34016882 | J Pediatr Gastroenterol Nutr | Transient Elastography in Pediatric Liver Disease. | 2021 | Details |
| A03398 | 34016738 | J Investig Med | Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease. | 2021 | Details |
| A03399 | 34016462 | Transplant Proc | Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center Study. | 2021 | Details |
| A03400 | 34015596 | Int Immunopharmacol | Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies. | 2021 | Details |
| A03402 | 34015069 | Med Ultrason | To screen or not to screen for NAFLD? | 2021 | Details |
| A03403 | 34014450 | Hepatol Int | Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice. | 2021 | Details |
| A03404 | 34014280 | Dis Model Mech | Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH. | 2021 | Details |
| A03405 | 34014044 | Pharmacol Res Perspect | Modulation of vascular contraction via soluble guanylate cyclase signaling in a novel ex vivo method using rat precision-cut liver slices. | 2021 | Details |
| A03406 | 34013366 | Int J Mol Med | Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review). | 2021 | Details |
| A03407 | 34013171 | iScience | Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease. | 2021 | Details |
| A03408 | 34012287 | J Inflamm Res | Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum. | 2021 | Details |
| A03409 | 34012007 | Sci Rep | Profiling of tumour-associated microbiota in human hepatocellular carcinoma. | 2021 | Details |
| A03410 | 34011624 | BMJ Open Gastroenterol | Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopy. | 2021 | Details |
| A03412 | 34011282 | BMC Cardiovasc Disord | Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis. | 2021 | Details |
| A03413 | 34010603 | Exp Eye Res | The role of peroxisome proliferator-activated receptors in healthy and diseased eyes. | 2021 | Details |
| A03414 | 34008183 | Hepatology | Maternal Early-Pregnancy Glucose Concentrations and Liver Fat Among School-Age Children. | 2021 | Details |
| A03415 | 34007802 | J Clin Transl Hepatol | Association of LDLR rs1433099 with the Risk of NAFLD and CVD in Chinese Han Population. | 2021 | Details |
| A03416 | 34007801 | J Clin Transl Hepatol | Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease. | 2021 | Details |
| A03417 | 34007325 | Exp Ther Med | Maternal obesity accelerated non-alcoholic fatty liver disease in offspring mice by reducing autophagy. | 2021 | Details |
| A03418 | 34007294 | Evid Based Complement Alternat Med | Mechanism of Huo-Xue-Qu-Yu Formula in Treating Nonalcoholic Hepatic Steatosis by Regulating Lipid Metabolism and Oxidative Stress in Rats. | 2021 | Details |
| A03419 | 34007127 | World J Gastroenterol | Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect. | 2021 | Details |
| A03420 | 34006994 | Eur J Clin Nutr | Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition? | 2021 | Details |
| A03421 | 34006921 | Sci Rep | Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach. | 2021 | Details |
| A03422 | 34006273 | BMC Endocr Disord | Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients. | 2021 | Details |
| A03423 | 34004366 | Ann Hepatol | NAFLD: Challenges and opportunities to address the public health problem in Latin America. | 2021 | Details |
| A03424 | 34004342 | J Nutr Biochem | Saskatoon berry powder reduces hepatic steatosis and insulin resistance in high fat-high sucrose diet-induced obese mice. | 2021 | Details |
| A03425 | 34004162 | Cell Metab | PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. | 2021 | Details |
| A03426 | 34004161 | Gastroenterology | Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03427 | 34003729 | Am J Respir Cell Mol Biol | Hepatocyte HIF-1 and Intermittent Hypoxia Independently Impact Liver Fibrosis in Murine Nonalcoholic Fatty Liver Disease. | 2021 | Details |